Surajeet Das Gupta, Sushmi Dey

Stories by Surajeet Das Gupta, Sushmi Dey

New drug pricing order challenged in court

New drug pricing order challenged in court

Rediff.com   1 Aug 2013

The move is expected to delay the introduction of low-priced medicines in the market.

US regulator tightens drug approval norms

US regulator tightens drug approval norms

Rediff.com   29 Jul 2013

Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics

9 drug firms may have to gulp Rs 2.5k-cr pill

9 drug firms may have to gulp Rs 2.5k-cr pill

Rediff.com   19 Jul 2013

Face NPPA fine for overcharging on anti-asthma drug

Three FDI offers fail transparency test

Three FDI offers fail transparency test

Rediff.com   15 Jul 2013

FIPB rejects proposals from firms that have not divulged details of beneficial ownership or source of funding

A tough challenge awaits AirAsia chief in India

A tough challenge awaits AirAsia chief in India

Rediff.com   10 Jul 2013

Given the cost structure in the country, it won't be easy for AirAsia to offer 'Nano' fares and still make money.

Govt to review suspension of 3 drugs

Govt to review suspension of 3 drugs

Rediff.com   10 Jul 2013

Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.

Ours is an FMCG company, not a chit fund: Amway chief

Ours is an FMCG company, not a chit fund: Amway chief

Rediff.com   10 Jul 2013

William S Pinckney was arrested by the Kerala police for alleged violation of the Prize Chits and Money Circulation Schemes (Banning) Act.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com   6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

Govt defends raising seats on UAE route

Govt defends raising seats on UAE route

Rediff.com   5 Jul 2013

Defending its decision to raise the number of seats under the India-United Arab Emirates (UAE) air services pact, the Civil Aviation Ministry, in a note to the Cabinet Secretariat and key ministries, has said no additional points of call have been allowed to the Gulf country.

Bajaj to move Pulsar output to Aurangabad

Bajaj to move Pulsar output to Aurangabad

Rediff.com   3 Jul 2013

Automaker to shift 200-300 workers from its Pantnagar facility to handle increased manufacturing.

Reprieve for Tata, RCom

Reprieve for Tata, RCom

Rediff.com   1 Jul 2013

DoT decides not to scrap dual-technology telecom licences

Bajaj may shift production to other plants

Bajaj may shift production to other plants

Rediff.com   28 Jun 2013

Confirming that the company could shift its production to other facilities, Bajaj Auto Managing Director Rajiv Bajaj told Business Standard: "If we take a view that this (labour issue) is going to extend over the next two months, we certainly can do that, and will do that."

Rajiv Bajaj on the strike at Chakan plant

Rajiv Bajaj on the strike at Chakan plant

Rediff.com   28 Jun 2013

Production has crippled at Bajaj Auto's Chakan plant in Maharashtra following a labour strike which entered its third day today.

Finally, health ministry acts on Uttarakhand

Finally, health ministry acts on Uttarakhand

Rediff.com   26 Jun 2013

Fearing outbreak of epidemics, the ministry is sending a high level team to review the public health measures in the area

Panel identifies 9 sectors for mandatory Indian control

Panel identifies 9 sectors for mandatory Indian control

Rediff.com   24 Jun 2013

These are FM radio, uplinking news & current affairs, print media (news & current affairs), commodity exchanges, stock exchanges along with depositories and clearing corporation, power exchanges, petroleum & natural gas refining, insurance, defence production and private security agencies.

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com   24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com   23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

Prices of key drugs to be cut by up to half

Prices of key drugs to be cut by up to half

Rediff.com   17 Jun 2013

The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.

Sun Pharma sues Novartis in US court

Sun Pharma sues Novartis in US court

Rediff.com   13 Jun 2013

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com   12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.